PTK2 and breast cancer: The inhibition of FAK phosphorylation in T47D breast cancer by SY-707 is well correlated with its concentrations in tumor tissues (Figure 5B), indicating a possible mechanism-based blockage ofin vivo tumor growth by SY-707.